This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Robinhood's Global Push: Is Now the Time to Buy HOOD Shares?
by Swayta Shah
Can HOOD's global expansion and crypto play justify the stock's premium valuation? Let's have a look at key factors before deciding whether to bet on it.
Stifel Reports Y/Y Rise in Client & Fee-Based Assets for April 2025
by Zacks Equity Research
SF grows client assets by 7% and fee-based assets by 11% y/y in April, which have been steady despite equity market volatility.
LPL Financial's April Brokerage & Advisory Assets Fall Sequentially
by Zacks Equity Research
LPLA's total brokerage and advisory assets dip sequentially in April to $1.79 trillion, with total organic NNAs touching $6.1 billion.
Schwab Shares Gain 1.1% as Total Client Assets Rise in April
by Zacks Equity Research
SCHW reports an increase in total client assets in April 2025 on the back of volatile markets.
Why The Charles Schwab Corporation (SCHW) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
LPL Financial's Q1 Earnings Beat on Higher Revenues, Expenses Soar
by Zacks Equity Research
Higher revenues and growth in brokerage and advisory assets support LPLA's Q1 earnings.
IBKR Stock Gains on Higher April DARTs: Should You Buy, Hold, or Sell?
by Ronit Masi
Interactive Brokers' shares gain 2.3% on a rise in April DARTs. Can it ride on product diversification efforts or will high costs dent its growth prospects?
Interactive Brokers Reports Y/Y Increase in April Client DARTs
by Zacks Equity Research
IBKR's client DARTs rise year over year on the back of an increase in total customer accounts, options and future contract growth.
Robinhood Q1 Earnings Top on Trading Surge & Higher NIR, Stock Up
by Zacks Equity Research
HOOD's first-quarter 2025 results surpass estimates on high net interest revenues and a surge in equity and options trading. Yet, higher costs are a woe.
Robinhood Set to Report Q1 Earnings: Here's How to Play HOOD Stock
by Zacks Equity Research
HOOD is set to announce its first-quarter 2025 results tomorrow. Do its diversification efforts make it a solid bet, or do tariff concerns dent its prospects?
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Robinhood Stock Falls 6.1% in a Month: Should You Buy, Sell or Hold?
by Ronit Masi
Robinhood stock falls 6.1% in a month. Can product diversification efforts offer support or will regulatory fines weigh on its growth? Let's find out.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Company News for Apr 21, 2025
by Zacks Equity Research
Companies in The News Are: BX,KEY,SCHW,RF
Charles Schwab (SCHW) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Charles Schwab (SCHW) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Schwab's Q1 Earnings and Revenues Beat Estimates, Stock Gains
by Zacks Equity Research
Higher revenues driven by net interest revenues and solid asset management performance support SCHW's Q1 earnings.
The Charles Schwab Corporation (SCHW) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Charles Schwab (SCHW) delivered earnings and revenue surprises of 4% and 1.48%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Subdued AUM Performance on Weak Markets to Hurt Invesco's Q1 Earnings
by Zacks Equity Research
Unfavorable market returns are expected to have hurt IVZ's AUM in Q1, thereby affecting its quarterly earnings.
The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment
by Zacks Equity Research
AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment are included in this Analyst Blog.
Top Research Reports for AbbVie, TJX & Charles Schwab
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), The TJX Companies, Inc. (TJX) and The Charles Schwab Corporation (SCHW), as well as two micro-cap stocks, Enzo Biochem, Inc. (ENZ) and CVD Equipment Corporation (CVV).
High Market Volatility and Rates to Aid Schwab's Q1 Earnings
by Zacks Equity Research
High trading revenues, NIR and asset management & administration fees are likely to have aided SCHW's first-quarter 2025 earnings amid elevated expenses.
Is Interactive Brokers Stock a Buy Before Q1 Earnings Release?
by Swayta Shah
IBKR will announce Q1 earnings tomorrow. Should the stock be part of your portfolio before the release? Let's find out.
Wells Fargo (WFC) Beats Q1 Earnings Estimates
by Zacks Equity Research
Wells Fargo (WFC) delivered earnings and revenue surprises of 3.25% and 3.12%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Charles Schwab (SCHW) Surges 7.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Charles Schwab (SCHW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.